Are Dr Agarwals Eye Hospital Ltd latest results good or bad?

Dr Agarwal's Eye Hospital Ltd has reported its financial results for Q1 FY27, showcasing a robust revenue performance with net sales reaching ₹142.97 crores, reflecting a year-on-year growth of 22.28%. This marks the eighth consecutive quarter of revenue growth, indicating a consistent upward trajectory driven by strong patient footfall and successful capacity expansion initiatives. The standalone net profit for the quarter was ₹23.38 crores, which represents a year-on-year increase of 35.46%. However, the operating margin has contracted by 148 basis points year-on-year to 30.26%, despite a sequential improvement from the previous quarter. This contraction suggests that while revenue is growing, the company is facing rising costs, particularly in employee expenses, which increased significantly year-on-year. The net profit margin also improved to 16.35% from 14.76% in the same quarter last year, primarily due to lower interest costs and favorable tax rates rather than operational efficiency gains. The company's balance sheet indicates an aggressive expansion strategy funded largely through debt, with long-term debt rising significantly. This has raised concerns about liquidity, as cash reserves have diminished, and interest costs have surged. The debt-to-equity ratio stands at 0.94 times, reflecting a moderate level of leverage that requires careful monitoring. Overall, while Dr Agarwal's Eye Hospital has demonstrated strong operational growth, the combination of margin pressure, increasing leverage, and liquidity concerns suggests that investors should approach with caution. The company has seen an adjustment in its evaluation, reflecting the complexities of its current financial landscape.